ANI Pharmaceuticals, Inc. (ANIP)
79.27
+1.26
(+1.62%)
USD |
NASDAQ |
May 18, 13:58
ANI Pharmaceuticals Research and Development Expense (Quarterly) : 10.60M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Liquidia Corp. | 12.27M |
| Indivior Pharmaceuticals, Inc. | 9.00M |
| Phathom Pharmaceuticals, Inc. | 7.771M |
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Assertio Holdings, Inc. | 0.454M |